Your browser doesn't support javascript.
loading
Bevacizumab dosing strategy in paediatric cancer patients based on population pharmacokinetic analysis with external validation.
Han, Kelong; Peyret, Thomas; Quartino, Angelica; Gosselin, Nathalie H; Gururangan, Sridharan; Casanova, Michela; Merks, Johannes H M; Massimino, Maura; Grill, Jacques; Daw, Najat C; Navid, Fariba; Jin, Jin; Allison, David E.
Afiliação
  • Han K; Clinical Pharmacology, Genentech Inc., South San Francisco, CA, USA.
  • Peyret T; Pharsight Consulting Services, Montreal, QC, Canada.
  • Quartino A; Clinical Pharmacology, Genentech Inc., South San Francisco, CA, USA.
  • Gosselin NH; Pharsight Consulting Services, Montreal, QC, Canada.
  • Gururangan S; Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC.
  • Casanova M; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
  • Merks JH; Department of Pediatric Oncology, Emma Children's Hospital-Academic Medical Center (EKZ-AMC), Amsterdam, The Netherlands.
  • Massimino M; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
  • Grill J; Gustave Roussy, Faculté de Médecine, University Paris-SUD, Villejuif, France.
  • Daw NC; Division of Pediatrics, MD Anderson Cancer Center, Houston, TX.
  • Navid F; Department of Oncology, St Jude Children's Research Hospital, Memphis, TN, USA.
  • Jin J; Clinical Pharmacology, Genentech Inc., South San Francisco, CA, USA.
  • Allison DE; Clinical Pharmacology, Genentech Inc., South San Francisco, CA, USA.
Br J Clin Pharmacol ; 81(1): 148-60, 2016 Jan.
Article em En | MEDLINE | ID: mdl-26345283

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores da Angiogênese / Bevacizumab / Neoplasias Tipo de estudo: Guideline / Prognostic_studies Limite: Adolescent / Adult / Child / Child, preschool / Humans / Infant Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores da Angiogênese / Bevacizumab / Neoplasias Tipo de estudo: Guideline / Prognostic_studies Limite: Adolescent / Adult / Child / Child, preschool / Humans / Infant Idioma: En Ano de publicação: 2016 Tipo de documento: Article